Skip to main content

Spider silk microcapsules could deliver vaccines to help battle cancer

Spider silk is a pretty darn versatile material. We previously covered research projects in which spider silk is used to help retrain nerves after major injuries, to improve the quality of microphones for use in hearing aids, and to form lightweight shields capable of absorbing enormous impacts. Now, researchers from Switzerland’s University of Geneva and other institutions have added one more innovative use case to the mix: Battling cancer.

In a new piece of work, they demonstrated how microcapsules made of artificial spider silk could be used to deliver potentially life-saving vaccines direct to your immune cells as a way of fighting cancerous tumors. When it comes to arachnid-themed entities fighting evildoers, you could think of them as your own personal tiny Spider-Man!

Recommended Videos

“Spider silk is light and very resistant,” professor Carole Bourquin, a specialist in anti-tumor immunotherapies who worked on the project, told Digital Trends. “It does not induce any inflammation or immune reaction in itself. We found that amazingly the microparticles can withstand high temperatures of more than 100 degrees Celsius (212 degrees Fahrenheit) for several hours. This suggests that they may protect vaccines in developing countries where refrigeration is frequently a problem for conventional vaccines.”

In their demonstration, the researchers used biotechnology to create the spider silk microcapsules. “It is basically a protein chain rolled up on itself like a ball of wool to form microparticles, into which we incorporated the vaccine,” Bourquin continued. “The microparticles protect the vaccine from being rapidly degraded in the body, and carry it to the immune cells where it is released and can induce an immune response. The immune response is much more effective with the transport system for the vaccine.”

They were able to successfully show that this spider silk-delivered vaccine generates strong T-lymphocyte responses, essential for protecting against cancer and certain infectious diseases, such as tuberculosis. While Bourquin noted that there is still more work to be done before the approach can be tested in patients, it appears extremely promising at this stage.

A paper describing the work, titled “Engineered hybrid spider silk particles as delivery system for peptide vaccines,” was recently published in the journal Biomaterials.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
BYD’s cheap EVs might remain out of Canada too
BYD Han

With Chinese-made electric vehicles facing stiff tariffs in both Europe and America, a stirring question for EV drivers has started to arise: Can the race to make EVs more affordable continue if the world leader is kept out of the race?

China’s BYD, recognized as a global leader in terms of affordability, had to backtrack on plans to reach the U.S. market after the Biden administration in May imposed 100% tariffs on EVs made in China.

Read more
Tesla posts exaggerate self-driving capacity, safety regulators say
Beta of Tesla's FSD in a car.

The National Highway Traffic Safety Administration (NHTSA) is concerned that Tesla’s use of social media and its website makes false promises about the automaker’s full-self driving (FSD) software.
The warning dates back from May, but was made public in an email to Tesla released on November 8.
The NHTSA opened an investigation in October into 2.4 million Tesla vehicles equipped with the FSD software, following three reported collisions and a fatal crash. The investigation centers on FSD’s ability to perform in “relatively common” reduced visibility conditions, such as sun glare, fog, and airborne dust.
In these instances, it appears that “the driver may not be aware that he or she is responsible” to make appropriate operational selections, or “fully understand” the nuances of the system, NHTSA said.
Meanwhile, “Tesla’s X (Twitter) account has reposted or endorsed postings that exhibit disengaged driver behavior,” Gregory Magno, the NHTSA’s vehicle defects chief investigator, wrote to Tesla in an email.
The postings, which included reposted YouTube videos, may encourage viewers to see FSD-supervised as a “Robotaxi” instead of a partially automated, driver-assist system that requires “persistent attention and intermittent intervention by the driver,” Magno said.
In one of a number of Tesla posts on X, the social media platform owned by Tesla CEO Elon Musk, a driver was seen using FSD to reach a hospital while undergoing a heart attack. In another post, a driver said he had used FSD for a 50-minute ride home. Meanwhile, third-party comments on the posts promoted the advantages of using FSD while under the influence of alcohol or when tired, NHTSA said.
Tesla’s official website also promotes conflicting messaging on the capabilities of the FSD software, the regulator said.
NHTSA has requested that Tesla revisit its communications to ensure its messaging remains consistent with FSD’s approved instructions, namely that the software provides only a driver assist/support system requiring drivers to remain vigilant and maintain constant readiness to intervene in driving.
Tesla last month unveiled the Cybercab, an autonomous-driving EV with no steering wheel or pedals. The vehicle has been promoted as a robotaxi, a self-driving vehicle operated as part of a ride-paying service, such as the one already offered by Alphabet-owned Waymo.
But Tesla’s self-driving technology has remained under the scrutiny of regulators. FSD relies on multiple onboard cameras to feed machine-learning models that, in turn, help the car make decisions based on what it sees.
Meanwhile, Waymo’s technology relies on premapped roads, sensors, cameras, radar, and lidar (a laser-light radar), which might be very costly, but has met the approval of safety regulators.

Read more
Waymo, Nexar present AI-based study to protect ‘vulnerable’ road users
waymo data vulnerable road users ml still  1 ea18c3

Robotaxi operator Waymo says its partnership with Nexar, a machine-learning tech firm dedicated to improving road safety, has yielded the largest dataset of its kind in the U.S., which will help inform the driving of its own automated vehicles.

As part of its latest research with Nexar, Waymo has reconstructed hundreds of crashes involving what it calls ‘vulnerable road users’ (VRUs), such as pedestrians walking through crosswalks, biyclists in city streets, or high-speed motorcycle riders on highways.

Read more